John H. Stone

AstraZeneca (United Kingdom) — United Kingdom

Medicine · Health Sciences

94h-index48.0kcitations646works6.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Vasculitis and related conditions(240), IgG4-Related and Inflammatory Diseases(185), Neuroendocrine Tumor Research Advances(105), Coagulation, Bradykinin, Polyphosphates, and Angioedema(88), Otitis Media and Relapsing Polychondritis(88)

Publications635 total

A novel cohort to assess longitudinal glucocorticoid toxicity in individuals with rheumatic diseases: objectives, design, and initial baseline characteristics of the LONG-TOX cohort
Seminars in Arthritis and Rheumatism·2025
EE580 Microsimulation Model to Estimate the Clinical and Cost Burden of Adverse Events Related to Long-Term Oral Corticosteroid Usage in Autoimmune Diseases in the United States
Value in Health·2025
A paradigm shift in corticosteroid therapy for sarcoidosis: a World Association of Sarcoidosis and Other Granulomatous Disorders Position Paper, endorsed by the Americas Association of Sarcoidosis and Other Granulomatous Disorders
The Lancet Respiratory Medicine·2025· 4 cited
Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitis
Nature Reviews Rheumatology·2025· 1 cited
3463 Real-world reduction in oral corticosteroid utilization at 1 year following efgartigimod initiation
2025Open Access
Burden of Metabolic Bone Disease in Patients with Immunoglobulin G4-Related Disease With and Without Autoimmune Pancreatitis: A Cross-Sectional Study
Clinical and Translational Gastroenterology·2025Open Access
EPH133 Targeted Literature Review and Qualitative Synthesis of the Burden of Oral Corticosteroid-Related Adverse Events in Autoimmune Conditions
Value in Health·2025
RWD145 Use of the Glucocorticoid Toxicity Index-Metabolic Domains Instrument to Quantify Glucocorticoid Toxicity in Adults With Chronic Inflammatory Demyelinating Polyneuropathy Using Electronic Health Records in the United States
Value in Health·2025
OP0189 SAFETY AND EFFICACY OF INEBILIZUMAB IN IgG4-RELATED DISEASE ACROSS VARIOUS PARTICIPANT DEMOGRAPHICS: SUBGROUP ANALYSIS FROM THE MITIGATE STUDY
Annals of the Rheumatic Diseases·2025Open Access
POS0009 Early Onset and Durability of Efficacy in Inebilizumab-treated Participants with IgG4 Related Disease: Post Hoc Analyses from the Phase 3 MITIGATE Trial
Annals of the Rheumatic Diseases·2025· 1 citedOpen Access
OP0186 EFFICACY AND SAFETY OF RILZABRUTINIB, AN ORAL BRUTON'S TYROSINE KINASE INHIBITOR, IN PATIENTS WITH IgG4-RELATED DISEASE: RESULTS FROM A 52-WEEK, PHASE 2, OPEN-LABEL, PROOF-OF-CONCEPT STUDY
Annals of the Rheumatic Diseases·2025· 2 citedOpen Access
POS0196-PARE STEROIDS AND ME: A PRACTICAL TOOL FOR SHARED DECISION-MAKING ABOUT GLUCOCORTICOID TAPERS
Annals of the Rheumatic Diseases·2025Open Access
Defining pancreatic damage and symptom burden in IgG4-related autoimmune pancreatitis: A cross-sectional study of 118 patients from a single-center registry
Seminars in Arthritis and Rheumatism·2025· 3 cited
Abstract 4826: Tyrosine kinase inhibitor combination therapies with AZD5851, dominant-negative TGFβRII armored anti-GPC3 CAR-T, for the treatment of hepatocellular carcinoma
Cancer Research·2025
Micro-mobility: A Policy Vacuum in Australia
Urban Policy and Research·2025· 1 cited
IgG4-related disease: lessons from the first 20 years
Lara D. Veeken·2025· 13 citedOpen Access
Granzyme K T cells and hypocomplementaemia in IgG4-RD
Pathology·2025
Pulmonary Manifestations of IgG4-Related Disease
2025
Defining cause of death in a contemporary cohort with ANCA-associated vasculitis (AAV): A comparison of electronic health record and death certificate data
Seminars in Arthritis and Rheumatism·2024· 1 citedOpen Access
Omics in IgG4-related disease
Chinese Medical Journal·2024· 2 citedOpen Access
page 1 of 32Next →

Frequent Co-authors

Vikram Deshpande(21), Arezou Khosroshahi(18), Mollie N. Carruthers(13), Zachary S. Wallace(11), Peter A. Merkel(9), Shiv Pillai(8), James R. Stone(7), Emanuel Della‐Torre(7), Hamid Mattoo(7), Vinay S. Mahajan(7), Yoh Zen(6), Kazuichi Okazaki(6), Hisanori Umehara(6), María C. Cid(5), Suresh T. Chari(5), Mitsuhiro Kawano(5), Takako Saeki(5), George Webster(5), Hyon K. Choi(5), Gary S. Hoffman(5)